{"id":"NCT02436304","sponsor":"Alcon Research","briefTitle":"Safety and Efficacy of EXE844 Otic Suspension in Otitis Media at Time of Tympanostomy Tube Insertion (OMTT) - Study 2","officialTitle":"Safety and Efficacy of EXE844 Otic Suspension in the Treatment of Otitis Media at Time of Tympanostomy Tube Insertion","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-06-19","primaryCompletion":"2016-08-04","completion":"2016-08-04","firstPosted":"2015-05-06","resultsPosted":"2017-08-28","lastUpdate":"2018-07-02"},"enrollment":404,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"SINGLE","primaryPurpose":"TREATMENT"},"conditions":["Otitis Media With Effusion in Children","Otitis Media Recurrent"],"interventions":[{"type":"DRUG","name":"EXE844 Sterile Otic Suspension, 0.3%","otherNames":[]},{"type":"PROCEDURE","name":"Tympanostomy Tube Insertion","otherNames":[]}],"arms":[{"label":"EXE844 for 7 Days + Tubes","type":"EXPERIMENTAL"},{"label":"EXE844 for 3 Days + Tubes","type":"EXPERIMENTAL"},{"label":"Tubes Only","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to evaluate EXE844 plus tympanostomy tubes compared to tympanostomy tubes only based on sustained clinical cure at end-of-therapy (EOT).","primaryOutcome":{"measure":"Percentage of Subjects With Sustained Clinical Cure at Day 8","timeFrame":"Day 8","effectByArm":[{"arm":"EXE844 7 Days","deltaMin":77.1,"sd":null},{"arm":"EXE844 3 Days","deltaMin":75.5,"sd":null},{"arm":"Tubes Only","deltaMin":65.3,"sd":null}],"pValues":[]},"eligibility":{"minAge":"6 Months","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":6},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":404},"commonTop":["Pyrexia","Ear Pain","Upper respiratory tract infection","Cough","Rhinorrhoea"]}}